Editorial: New advancement in tumor microenvironment remodeling and cancer therapy

被引：1
作者：
Yao, Yi [1 ,2 ]
Shen, Ying [3 ,4 ,5 ]
Yao, James C. [6 ]
Zuo, Xiangsheng [6 ]
机构：
[1] Wuhan Univ, Canc Ctr, Renmin Hosp, Wuhan, Peoples R China
[2] Hubei Prov Res Ctr Precis Med Canc, Wuhan, Peoples R China
[3] State Key Lab Oncol South China, Guangzhou, Peoples R China
[4] Guangdong Prov Peoples Hosp, Ctr Canc, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Canc Ctr, Guangzhou, Peoples R China
[6] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
来源：
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY | 2024年 / 12卷
关键词：
TME; cancer therapeutics; immune check inhibitor; PD-L1; tumor mutational burden; OBINUTUZUMAB; EXPRESSION;
D O I：
10.3389/fcell.2024.1384567
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页数：4
相关论文
共 25 条
[1]   Remodeling of Stromal Cells and Immune Landscape in Microenvironment During Tumor Progression [J].
Arora, Leena ;
Pal, Durba .
FRONTIERS IN ONCOLOGY, 2021, 11
[2]   Therapy-Induced Modulation of the Tumor Microenvironment: New Opportunities for Cancer Therapies [J].
Benavente, Sergi ;
Sanchez-Garcia, Almudena ;
Naches, Silvia ;
Esther LLeonart, Matilde ;
Lorente, Juan .
FRONTIERS IN ONCOLOGY, 2020, 10
[3]   Expression of B7-H2 on CD8+ T cells in colorectal cancer microenvironment and its clinical significance [J].
Cao, Ya ;
Cao, Tinghua ;
Zhao, Weidong ;
He, Fanghua ;
Lu, Ye ;
Zhang, Guangbo ;
Hu, Hao ;
Wang, Zhenxin .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2018, 56 :128-134
[4]   Tumor Microenvironment: A Metabolic Player that Shapes the Immune Response [J].
Cassim, Shamir ;
Pouyssegur, Jacques .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (01)
[5]   Mechanisms Controlling PD-L1 Expression in Cancer [J].
Cha, Jong-Ho ;
Chan, Li-Chuan ;
Li, Chia-Wei ;
Hsu, Jennifer L. ;
Hung, Mien-Chie .
MOLECULAR CELL, 2019, 76 (03) :359-370
[6]   Autophagy and doxorubicin resistance in cancer [J].
Chen, Chao ;
Lu, Lu ;
Yan, Shichao ;
Yi, Huimei ;
Yao, Hui ;
Wu, Di ;
He, Guangchun ;
Tao, Xiaojun ;
Deng, Xiyun .
ANTI-CANCER DRUGS, 2018, 29 (01) :1-9
[7]   In situ expression and significance of B7 costimulatory molecules within tissues of human gastric carcinoma [J].
Chen, XL ;
Cao, XD ;
Kang, AJ ;
Wang, KM ;
Su, BS ;
Wang, YL .
WORLD JOURNAL OF GASTROENTEROLOGY, 2003, 9 (06) :1370-1373
[8]   3D Cancer Models: Depicting Cellular Crosstalk within the Tumour Microenvironment [J].
Franchi-Mendes, Teresa ;
Eduardo, Rodrigo ;
Domenici, Giacomo ;
Brito, Catarina .
CANCERS, 2021, 13 (18)
[9]   Obinutuzumab for relapsed or refractory indolent non-Hodgkin's lymphomas [J].
Gabellier, Ludovic ;
Cartron, Guillaume .
THERAPEUTIC ADVANCES IN HEMATOLOGY, 2016, 7 (02) :85-93
[10]   Obinutuzumab plus Chlorambucil in Patients with CLL and Coexisting Conditions [J].
Goede, Valentin ;
Fischer, Kirsten ;
Busch, Raymonde ;
Engelke, Anja ;
Eichhorst, Barbara ;
Wendtner, Clemens M. ;
Chagorova, Tatiana ;
de la Serna, Javier ;
Dilhuydy, Marie-Sarah ;
Illmer, Thomas ;
Opat, Stephen ;
Owen, Carolyn J. ;
Samoylova, Olga ;
Kreuzer, Karl-Anton ;
Stilgenbauer, Stephan ;
Doehner, Hartmut ;
Langerak, Anton W. ;
Ritgen, Matthias ;
Kneba, Michael ;
Asikanius, Elina ;
Humphrey, Kathryn ;
Wenger, Michael ;
Hallek, Michael .
NEW ENGLAND JOURNAL OF MEDICINE, 2014, 370 (12) :1101-1110
123